专题：Head and Neck Cancer Studies

This cluster of papers focuses on the epidemiology, treatment, and prognosis of head and neck cancer, with a particular emphasis on human papillomavirus (HPV)-related oropharyngeal cancer. It covers topics such as the impact of HPV infection, the role of radiotherapy and chemotherapy, survival outcomes, and the molecular landscape of head and neck squamous cell carcinomas.
最新文献
Effects of diagnostic delays in head and neck cancer patients presenting to the emergency department

article Full Text OpenAlex

Selected laryngeal squamous cell carcinomas with laryngeal mobility impairment are suitable for curative larynx-preservation treatment

article Full Text OpenAlex

Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact

article Full Text OpenAlex

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

article Full Text OpenAlex

A Targeted Approach to Dental Treatment for Patients Prior To and After Head and Neck Radiation

review Full Text OpenAlex

Life following total laryngectomy: mixed-model analyses of longitudinal patient-reported outcomes in a prospective cohort

article Full Text OpenAlex

Beyond the ratio of tumor reduction: residual volume after induction chemotherapy emerges as the optimal biomarker in advanced nasopharyngeal cancer

article Full Text OpenAlex

Assessing the prognostic significance and predictive features of cervical occult metastasis in glottic laryngeal squamous cell carcinoma

article Full Text OpenAlex

Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivors

article Full Text OpenAlex

Lateralised T3/T4N0 Oral Squamous Cell Carcinoma. Is Contralateral Elective Neck Dissection or Neck Radiotherapy Indicated? A Multicentre Retrospective Study

article Full Text OpenAlex

近5年高被引文献
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

article Full Text OpenAlex 1198 FWCI226.951

HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

review Full Text OpenAlex 640 FWCI54.431

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

article Full Text OpenAlex 499 FWCI88.486

Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors

article Full Text OpenAlex 480 FWCI119.291

Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma

review Full Text OpenAlex 426 FWCI56.304

Nasopharyngeal carcinoma: an evolving paradigm

review Full Text OpenAlex 409 FWCI11.794

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

article Full Text OpenAlex 400 FWCI100.763

Oral squamous cell carcinomas: state of the field and emerging directions

review Full Text OpenAlex 385 FWCI33.249

Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics

review Full Text OpenAlex 375 FWCI17.729

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

article Full Text OpenAlex 338 FWCI60.099